Hiraku Onishi

Summary

Affiliation: Hoshi University
Country: Japan

Publications

  1. ncbi Kinetic analysis of in vitro and in vivo release of prednisolone from the conjugate of glycol-chitosan and succinyl-prednisolone
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Tokyo, 2 4 41, Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Int J Pharm 410:17-22. 2011
  2. ncbi Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: comparison of simple and conjugate microspheres
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 31:597-605. 2005
  3. ncbi Novel mucoadhesive oral patch containing diazepam
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Drug Dev Ind Pharm 31:607-13. 2005
  4. ncbi Antitumor properties of irinotecan-containing nanoparticles prepared using poly(DL-lactic acid) and poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Biol Pharm Bull 26:116-9. 2003
  5. ncbi Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Drug Dev Ind Pharm 33:641-7. 2007
  6. ncbi Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Ebara, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 33:848-54. 2007
  7. ncbi Lactoferrin delivery systems: approaches for its more effective use
    Hiraku Onishi
    Hoshi University, Department of Drug Delivery Research, Ebara, Shinagawa ku, Tokyo, Japan
    Expert Opin Drug Deliv 8:1469-79. 2011
  8. ncbi Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size
    H Onishi
    Department of Drug Delivery Research, Hoshi University, Ebara, Tokyo, Japan
    Drug Dev Ind Pharm 27:659-67. 2001
  9. ncbi PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University Tokyo 142 8501, Japan
    Biol Pharm Bull 28:2011-5. 2005
  10. ncbi Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 36:879-84. 2010

Collaborators

  • Yoshinori Kato
  • Akihiko Ito
  • Hiroyuki Suzuki
  • T Yamada
  • Kozo Takayama
  • Yayoi Kawano
  • H Takahashi
  • Kentaro Inoue
  • Yoshiharu Machida
  • Osamu Sakata
  • Masanaho Sasatsu
  • Yuri Takahashi
  • Takuma Koseki
  • Tomoko Oosegi
  • Ryotaro Kunii
  • Kenta Yamamoto
  • Ken ichi Koyama
  • Keisuke Yamato
  • Nobuyuki Ishiki
  • Kenji Yamabe
  • Tsuneji Nagai
  • Ken Katayama
  • Takashi Masutomi
  • Minoru Uchida
  • Shuichi Aoyagi
  • Kaori Hirose
  • Kazuyuki Tsuji
  • Chikako Takeda
  • Hidero Akiyama
  • Mika Hori
  • Hidetaka Miura
  • Mari Takahashi
  • Tomoaki Yoshino
  • Junko Takishima
  • Osamu Ishikawa
  • J Shimoda
  • Ken ichi Ueki
  • Ken-ichi Ueki
  • Ken-ichi Koyama
  • Isamu Seto
  • Koichi Isowa
  • Kazuo Takeshita
  • Kazuto Kouzuma
  • Genji Kawano
  • Y Machida

Detail Information

Publications66

  1. ncbi Kinetic analysis of in vitro and in vivo release of prednisolone from the conjugate of glycol-chitosan and succinyl-prednisolone
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Tokyo, 2 4 41, Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Int J Pharm 410:17-22. 2011
    ..From these results, it is expected that GC-SP will be accumulated at inflammatory sites based on enhanced permeability and retention (EPR) effects, and release PD there effectively...
  2. ncbi Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: comparison of simple and conjugate microspheres
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 31:597-605. 2005
    ..These characteristics on particle size and in vitro release suggested that Ch-SP-MS should have good potential as a microparticulate system for the treatment of IBD...
  3. ncbi Novel mucoadhesive oral patch containing diazepam
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Drug Dev Ind Pharm 31:607-13. 2005
    ..It was demonstrated that the patch with OA showed a good adhesion to oral mucosa and worked efficiently for rapid absorption of DZ...
  4. ncbi Antitumor properties of irinotecan-containing nanoparticles prepared using poly(DL-lactic acid) and poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Biol Pharm Bull 26:116-9. 2003
    ..After i.v. injection in rats, NP maintained irinotecan plasma concentration longer than CPT-11 aqueous solution. The present nanoparticle formation is suggested as a possibly useful dosage form of irinotecan against solid tumor...
  5. ncbi Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Drug Dev Ind Pharm 33:641-7. 2007
    ..Considering the mucoadhesive properties of chitosan microparticles, Ch-LF(N) are suggested to be useful for gradual supply to topical diseased sites or for effective delivery to intestinal areas with abundant LF receptors...
  6. ncbi Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Ebara, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 33:848-54. 2007
    ..2, and gradually released Ch-SP-MS at pH 6.8 and 7.4 due to dissolution of the Eudragit layer. Eudragit coating is suggested to be useful to efficiently deliver Ch-SP-MS to the intestinal disease sites...
  7. ncbi Lactoferrin delivery systems: approaches for its more effective use
    Hiraku Onishi
    Hoshi University, Department of Drug Delivery Research, Ebara, Shinagawa ku, Tokyo, Japan
    Expert Opin Drug Deliv 8:1469-79. 2011
    ..These delivery systems are expected to improve the utility of LF...
  8. ncbi Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size
    H Onishi
    Department of Drug Delivery Research, Hoshi University, Ebara, Tokyo, Japan
    Drug Dev Ind Pharm 27:659-67. 2001
    ..45 microm (Suc-MP-MMC) were derived by the addition of EDC before emulsification. Suc-MP-MMC exhibited a higher drug content than CML-MP-MMC. CML-MP-MMC and Suc-MP-MMC exhibited 50% drug release times of 2.87h and 42.1 h, respectively...
  9. ncbi PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University Tokyo 142 8501, Japan
    Biol Pharm Bull 28:2011-5. 2005
    ..As the implant displayed the discrepancy between in vitro and in vivo release rates, the improvement of the in vivo release rate is required...
  10. ncbi Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 36:879-84. 2010
    ..Therefore, it is important to develop a system delivering LF efficiently to intestinal mucosa or gut-associated lymphoid tissue...
  11. ncbi Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo, Japan
    Int J Pharm 358:296-302. 2008
    ..It was demonstrated that Ch-SP-MS/EuL enhanced effectiveness of PD and reduced toxic side effects of PD greatly. Also, these results established the prediction by previous in vitro and in vivo studies...
  12. ncbi [Development of semisolid dosage form of clonazepam for oral cavity administration]
    Osamu Sakata
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Yakugaku Zasshi 130:119-25. 2010
    ..It is proposed that the semisolid dosage form CZP1-PEG-OA should be a possibly useful preparation for the antiepileptic or sedative medication...
  13. ncbi In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, 2 4 41, Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Molecules 13:2136-55. 2008
    ..In this review, several micro- or nanoparticles composed of macromolecule-drug conjugates are described for their preparation, in vitro properties and/or in vivo behavior...
  14. ncbi Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis
    Tomoko Oosegi
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Int J Pharm 348:80-8. 2008
    ..Ch-SP-MS/EuL are suggested as a useful delivery system to the site of inflammatory bowel disease...
  15. ncbi Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin
    Ken ichi Koyama
    Department of Pharmacy, The Fraternity Memorial Hospital, Tokyo, Japan
    Yakugaku Zasshi 129:1507-14. 2009
    ..8, though swelling and softening of the microparticles occurred at pH 6.8. It is suggested that alginate/calcium complex microparticles coated with 0.25-0.5% (w/v) chitosan solution would be useful for the intestinal delivery of LF...
  16. ncbi Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles
    Ryotaro Kunii
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Drug Deliv 15:3-10. 2008
    ..As compared with CPT solution, CPT-NP showed higher tissue accumulation and better tumor localization, which were considered essentially associated with the better efficacy of CPT-NP reported in the previous study...
  17. ncbi Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin
    Ryotaro Kunii
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Eur J Pharm Biopharm 67:9-17. 2007
    ..The PLA/PEG-PPG-PEG nanoparticles were considered potentially useful to enhance the efficacy of CPT, to which the high drug retention in the body and gradual drug release appeared to be importantly related...
  18. ncbi In vitro and in vivo evaluation of medicinal carbon granules and tablet on the adsorption of acetaminophen
    Kenta Yamamoto
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Int J Pharm 328:105-11. 2007
    ..Thus, granules and tablet are useful as a compact dosage form of MC; though the reduced adsorption capacity must be taken into account in order to expect efficacy equivalent to that of MC alone...
  19. ncbi Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid)
    Masanaho Sasatsu
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo, Japan
    Int J Pharm 358:271-7. 2008
    ..It is suggested that PLA-pyrene might be a useful probe of the nanoparticles themselves. In addition, it was demonstrated that PLA-(MeO-PEG) nanoparticles should be a useful drug carrier for passive tumor targeting...
  20. ncbi Preparation and evaluation of novel directly-compressed fast-disintegrating furosemide tablets with sucrose stearic acid ester
    Takuma Koseki
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Biol Pharm Bull 32:1126-30. 2009
    ..It was demonstrated that the present direct compression using homogeneous FS/S1670/MC powder mixture could give an excellent fast-disintegrating tablet of FS...
  21. ncbi Tumour cell uptake of lactosaminated and intact N-succinyl-chitosans and antitumour effects of conjugates with mitomycin C
    Yoshinori Kato
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Anticancer Res 22:2771-6. 2002
    ....
  22. ncbi [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method]
    Yayoi Kawano
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Yakugaku Zasshi 130:1737-42. 2010
    ..FU ODTs with improved taste, rapid disintegration and greater hardness could be prepared with YO-containing granules made by the wet granulation method using MA as a binding agent...
  23. ncbi Semi-solid dosage form of clonazepam for rapid oral mucosal absorption
    Osamu Sakata
    Department of Drug Delivery Research, Hoshi University, Ebara, Shinagawa ku, Tokyo, Japan
    Drug Dev Ind Pharm 37:809-14. 2011
    ..Therefore, in the present study, it was attempted to develop an easily-handled dosage form, which was more physically stable and allowed rapid drug absorption from oral mucosa...
  24. ncbi Acetaminophen-containing chewable tablets with suppressed bitterness and improved oral feeling
    Hiroyuki Suzuki
    Department of Drug Delivery Research, Hoshi University, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 278:51-61. 2004
    ..Thus, the Witocan H tablet with Sc1-B5 is suggested as the best acetaminophen chewable tablet, exhibiting suppressed bitterness, low sweetness, improved oral feeling and good drug release...
  25. ncbi Influence of pectins on preparation characteristics of lactoferrin bioadhesive tablets
    Chikako Takeda
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Chem Pharm Bull (Tokyo) 55:1164-8. 2007
    ..Furthermore, a possibility that the B-LF release could be controlled by adjusting the Ca(2+) concentration in Ca-PC was suggested...
  26. ncbi Development of implant tablet for a week-long sustained release
    Mari Takahashi
    Department of Drug Delivery Research, Hoshi University, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    J Control Release 100:63-74. 2004
    ..The present implant tablet is suggested to be useful as a drug delivery system for supplying drugs for approximately 1 week...
  27. ncbi Effect of penetration enhancers on transdermal delivery of propofol
    Keisuke Yamato
    Department of Drug Delivery Research, Hoshi University, Japan
    Biol Pharm Bull 32:677-83. 2009
    ..Our findings suggest that the combination of PG and MEN was useful as enhancers for the transdermal absorption of PF. These results provide useful information to develop a transdermal dosage form of PF as a sedative or a hypnotic...
  28. ncbi Macromolecular and nanotechnological modification of camptothecin and its analogs to improve the efficacy
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University, 2 4 41, Ebara, Tokyo 142 8501, Japan
    Curr Drug Discov Technol 2:169-83. 2005
    ..In these systems, one of the most important concepts is the enhanced permeability and retention (EPR) effect. The outcomes obtained by these approaches are displayed by introducing concrete examples...
  29. ncbi Evaluation of binders in the preparation of medicinal carbon tablets by wet granule compression
    Akihiko Ito
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Yakugaku Zasshi 126:315-9. 2006
    ..Similar adsorption characteristics were also observed in a real drug, acetaminophen. It is suggested that the MC tablets prepared by the wet granule compression using MT as a binder should be useful as a compact dosage form of MC...
  30. ncbi Antitumor characteristics of methoxypolyethylene glycol-poly(DL-lactic acid) nanoparticles containing camptothecin
    Hidetaka Miura
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa, Tokyo 142-8501, Japan
    J Control Release 97:101-13. 2004
    ..After i.v. administration to the tumor-bearing mice, CPT-NP showed better plasma retention, and high and long tumor localization. CPT-NP are suggested to greatly improve the efficacy of CPT due to their pharmacokinetic features...
  31. ncbi Double liposomes: hypoglycemic effects of liposomal insulin on normal rats
    Ken Katayama
    Department of Drug Delivery Research, Hoshi University, Shinagawa-ku, Tokyo, Japan
    Drug Dev Ind Pharm 29:725-31. 2003
    ..These results suggest that DLs are applicable as an oral dosage form for peptide drugs such as insulin etc., especially in combination with protease inhibitors...
  32. ncbi Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system
    Tomoko Oosegi
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Eur J Pharm Biopharm 68:260-6. 2008
    ..8. These particle characteristics and in vitro behaviors demonstrated that the present Eudragit-coated Ch-SP-MS were considered potentially suitable for in vivo or practical application as a specific delivery system of PD to IBD sites...
  33. ncbi Application of chitin and chitosan derivatives in the pharmaceutical field
    Yoshinori Kato
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Curr Pharm Biotechnol 4:303-9. 2003
    ..This review summarizes the application of chitin and chitosan derivatives for hospital preparations and drug carriers...
  34. ncbi Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates
    Nobuyuki Ishiki
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa, Tokyo 142-8501, Japan
    Int J Pharm 279:81-93. 2004
    ..The presence of the tumor itself influenced the body weight and leukocyte number. However, toxic side effects could be evaluated from the body weight and leukocyte number to almost the same extent between tumor-bearing and normal mice...
  35. ncbi In vitro and in vivo characterization of nanoparticles made of MeO-PEG amine/PLA block copolymer and PLA
    Masanaho Sasatsu
    Department of Drug Delivery Research, Hoshi University, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 317:167-74. 2006
    ..It is suggested that the PLA/PLA-(MeO-PEG) mixture nanoparticles with a higher PEG/PLA ratio should be useful as a carrier for the elevation of the plasma concentration of lipophilic drugs...
  36. ncbi Glycyrrhetic acid-loaded microparticles: liver-specific delivery and therapeutic potential against carbon tetrachloride-induced hepatitis
    Hiroaki Takahashi
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    J Pharm Pharmacol 56:437-44. 2004
    ..MPs are suggested as a possible useful system to prolong the therapeutic effect of GLA...
  37. ncbi Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent
    Takuma Koseki
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Chem Pharm Bull (Tokyo) 56:1384-8. 2008
    ..These properties were considered to result from well-mixed and fine-powdered SSE and FS...
  38. ncbi Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system
    Mika Hori
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 297:223-34. 2005
    ..OVA-specific IgA was induced significantly more efficiently by ER-Chi-OVA than the others. These suggested that ER-Chi-OVA should be possibly useful to induce an intestinal mucosal immune response...
  39. ncbi Preparation and characterization of chitosan microspheres containing doxifluridine
    Tomoaki Yoshino
    Department of Pharmaceutics, Hoshi University, Ebara, Shinagawa-ku, Tokyo, Japan
    Drug Dev Ind Pharm 29:417-27. 2003
    ..DFUR-containing chitosan microspheres with fairly large size and good drug content could be obtained by the present preparation but remained to be improved for drug release properties...
  40. ncbi Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats
    Junko Takishima
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Biol Pharm Bull 25:1498-502. 2002
    ..Only Chi-MPC suppressed the initial plasma level and maintained the plasma concentration for a long time up to 24 h, suggesting Chi-MPC would be useful for prolonged intestinal absorption of cephradine...
  41. ncbi Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer
    Yoshinori Kato
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    J Pharm Pharmacol 54:529-37. 2002
    ..Further, with intravenous administration at 3 days post-inoculation, Suc(II)-MMC exhibited a much higher survival effect at a dose of 4 mg kg(-1) for 4 days...
  42. ncbi Clonazepam oral droplets for the treatment of acute epileptic seizures
    Osamu Sakata
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Drug Dev Ind Pharm 34:1376-80. 2008
    ..It is suggested that a droplet of CZ/OA/propylene glycol (2.5:5.0:92.5, wt/wt) might be useful as an alternative to i.v. injection of CZ for the treatment of acute epileptic seizures...
  43. ncbi N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates
    Yoshinori Kato
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, 142 8501 Tokyo, Japan
    Biomaterials 25:907-15. 2004
    ..This review summarizes the utilization of Suc-Chi as a drug carrier for macromolecular conjugates of MMC and the therapeutic efficacy of the conjugates against various tumours...
  44. ncbi In vivo evaluation of Kumazasa extract and chitosan films containing the extract against deep skin ulcer model in rats
    Kaori Hirose
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Biol Pharm Bull 30:2406-11. 2007
    ..Although FD films were less effective than KE alone, they were superior as to usability such as changing the preparation...
  45. ncbi Medicinal carbon tablets for treatment of acetaminophen intoxication: adsorption characteristics of medicinal carbon powder and its tablets
    Kenta Yamamoto
    Department of Drug Delivery Research, Hoshi University, Ebara, Tokyo, Japan
    Chem Pharm Bull (Tokyo) 54:359-62. 2006
    ..The tablet showed good adsorption potential for acetaminophen, though the adsorption rate and extent of the tablet were reduced to some extent as compared with powder...
  46. ncbi Antitumor activities of conjugates of mitomycin C with estradiol benzoate and estradiol via glutaric acid in suspension dosage form
    Nobuyuki Ishiki
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Biol Pharm Bull 25:1373-7. 2002
    ..With regard to chemotherapy against sarcoma 180, both conjugates were considered to supply MMC slowly but effectively at higher doses...
  47. ncbi Biodistribution study using Egg Protein ELISA kit after administration of FITC-labeled ovalbumin solution and its double liposomes in the in situ loop method, and its implication in oral immunization
    Takashi Masutomi
    Department of Drug Delivery Research, Hoshi University, 2 4 41, Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Curr Drug Deliv 7:447-52. 2010
    ..In addition, the double liposomes could retain OVA longer in PP, which might cause the enhancement of oral immunization...
  48. ncbi Potentiality of double liposomes containing salmon calcitonin as an oral dosage form
    Kenji Yamabe
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    J Control Release 89:429-36. 2003
    ..05). Therefore, it is speculated that not only the size of liposomes but also the cationic charge plays an important role in the intestinal absorption of DL. These findings suggested the utility of DL as an oral dosage form of SCT...
  49. ncbi Preparation of a PLA-PEG block copolymer using a PLA derivative with a formyl terminal group and its application to nanoparticulate formulation
    Masanaho Sasatsu
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 294:233-45. 2005
    ..It is suggested that PLA-aldehyde should be useful as a functional intermediate for derivatization of PLA, and PLA-(MeO-PEG(N)) can be used for the preparation of PEG-coated PLA nanoparticles...
  50. ncbi Transdermal absorption of propofol in rats
    Yuri Takahashi
    Department of Drug Delivery Research, Hoshi University, Tokyo 142 8501, Japan
    Biol Pharm Bull 28:870-5. 2005
    ..These results indicate that the combination of PF and PG was appropriate for the transdermal absorption of PF, and PF was absorbed through the rat skin to an extent sufficient to cause a continuous sedative effect...
  51. ncbi In vitro characteristics of liposomes and double liposomes prepared using a novel glass beads method
    Kenji Yamabe
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    J Control Release 90:71-9. 2003
    ..These findings suggested that the glass beads method developed in this study conferred a high drug loading and a high DL formation on liposomes compared with ordinary methods...
  52. ncbi Preparation of novel double liposomes using the glass-filter method
    Ken Katayama
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 248:93-9. 2002
    ..The glass-filter method is the only method that we can get the double liposomes in a short period, and double liposomes prepared by this novel method had adequate size and good stability in vitro...
  53. ncbi [Nanoparticles prepared with PLA derivatives]
    Hiraku Onishi
    Department of Drug Delivery Research, Hoshi University
    Nippon Rinsho 64:225-30. 2006
    ..In this section, the preparative procedure of PLA derivaties and several nanoparticles prepared with PLA derivatives are introduced. Moreover, the physicochemical and biopharmaceutical characteristics of the nanoparticles are overviewed...
  54. ncbi Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice
    Y Kato
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan
    J Control Release 70:295-307. 2001
    ..Thus, Lac-Suc was found available as a carrier exhibiting a high affinity to and long retention in the liver...
  55. ncbi Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds
    Shuichi Aoyagi
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Int J Pharm 330:138-45. 2007
    ..Considering the elimination of pus, CH83-MH2-A tended to be better than CH83 film. CH83-MH2-A is suggested as a useful formulation for the treatment of severe burn wounds...
  56. ncbi Development of oral acetaminophen chewable tablets with inhibited bitter taste
    Hiroyuki Suzuki
    Department of Drug Delivery Research, Hoshi University, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 251:123-32. 2003
    ..The dosage forms best masking bitter taste showed good release of the drug, indicating little change in bioavailability by masking...
  57. ncbi Enhancement of transdermal absorption by switching iontophoresis
    Osamu Ishikawa
    Department of Drug Delivery Research, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo 142-8501, Japan
    Int J Pharm 249:81-8. 2002
    ..These results suggested that enhancement of skin hydration plays an important role in the enhancing effect of switching iontophoresis on skin permeation...
  58. ncbi Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice
    Y Kato
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Biol Pharm Bull 23:1497-503. 2000
    ..v. administration were higher than those at 8 h after i.p. administration. These suggested more localization of the conjugate in peripheral tissues and less excretion at i.p. administration, which might result in greater toxicity...
  59. ncbi Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis
    Y Kato
    Department of Drug Delivery Research, Hoshi University, 2 4 41 Ebara, Shinagawa ku, Tokyo 142 8501, Japan
    Int J Pharm 226:93-106. 2001
    ..MMC/kg). Both carriers, Suc showing systemic long-circulation and Lac-Suc with an ability of liver-specific localization, are thought to be drug carriers with potentialities for therapeutics at early stage of metastasis...
  60. ncbi Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer
    Y Kato
    Department of Clinical Pharmacy, Hoshi University, Tokyo, Japan
    Biomaterials 21:1579-85. 2000
    ..The ratio of tumor accumulation reached a plateau at 48 h after injection, and the accumulation level, approximately 10%, was similar to those observed for other reported long-circulating macromolecules...
  61. ncbi Depolymerization of N-succinyl-chitosan by hydrochloric acid
    Yoshinori Kato
    Department of Drug Delivery Research, Hoshi University, Tokyo, Japan
    Carbohydr Res 337:561-4. 2002
    ..The intrinsic viscosity ([eta]) obtained at the concentration of 0.1-0.3% (w/v) in saline showed a linear relationship between log[eta] and log MW, which provided the coefficients in the Mark-Houwink equation...
  62. ncbi In vitro and in vivo evaluation of sustained release chitosan-coated ketoprofen microparticles
    T Yamada
    Department of Drug Delivery Research, 2-4-41, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
    Yakugaku Zasshi 121:239-45. 2001
    ..Chi-MP showed a good mucoadhesion. The maximum plasma concentration of ketoprofen for Chi-MP was less than one-third of that for ketoprofen powder suspension. Chi-MP tended to show the higher and steadier plasma level than MS...
  63. ncbi Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine
    J Shimoda
    Department of Clinical Pharmacy, Hoshi University, Tokyo, Japan
    Drug Dev Ind Pharm 27:567-76. 2001
    ..The present chitosan microsphere system showed good adhesion to the intestinal mucosa, but scarcely facilitated absorption of insulin...
  64. ncbi Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose
    T Yamada
    Department of Drug Delivery Research, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, 142-8501, Tokyo, Japan
    J Control Release 75:271-82. 2001
    ..Kinetic analysis demonstrated that formation I showed a nearly zero-order release rate in vivo consistent with that observed in vitro...
  65. ncbi Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model
    Kentaro Inoue
    Second Department of Surgery, Kansai Medical University, Osaka, Japan
    Cancer Chemother Pharmacol 53:415-22. 2004
    ..To identify the optimal schedule for intraperitoneal (i.p.) infusion of floxuridine (FUDR) against peritoneal micrometastases from gastric cancer...
  66. ncbi Contribution of chitosan and its derivatives to cancer chemotherapy
    Yoshinori Kato
    The Johns Hopkins University School of Medicine, Department of Radiology, Division of MR Research, Oncology Section, Baltimore, MD 21205, USA
    In Vivo 19:301-10. 2005
    ..It is believed that the chitin and chitosan derivatives discussed in this review are good candidates for a polymeric drug carrier in cancer chemotherapy...